SignatureFD’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.34K Hold
46
– – ﹤0.01% 3054
2026
Q2
$3.81K Hold
46
– – ﹤0.01% 2951
2026
Q1
$3.54K Hold
46
– – ﹤0.01% 2893
2025
Q4
$3.63K Hold
46
– – ﹤0.01% 2804
2025
Q3
$4.21K Hold
46
– – ﹤0.01% 2738
2025
Q2
$3K Buy
46
+8
+21% +$521 ﹤0.01% 2752
2025
Q1
$2.54K Hold
38
– – ﹤0.01% 2810
2024
Q4
$2.1K Hold
38
– – ﹤0.01% 2853
2024
Q3
$2.27K Hold
38
– – ﹤0.01% 2807
2024
Q2
$2.42K Hold
38
– – ﹤0.01% 2714
2024
Q1
$2.63K Hold
38
– – ﹤0.01% 2729
2023
Q4
$2.1K Hold
38
– – ﹤0.01% 2748
2023
Q3
$2.21K Hold
38
– – ﹤0.01% 2746
2023
Q2
$2.05K Hold
38
– – ﹤0.01% 2803
2023
Q1
$1.51K Sell
38
-23
-38% -$970 ﹤0.01% 2881
2022
Q4
$2.45K Buy
61
+38
+165% +$1.43K ﹤0.01% 2738
2022
Q3
$1K Buy
+23
New +$787 ﹤0.01% 2901

Other funds holding ANIP

SignatureFD's ANIP Position: Q3 2026 in Review

SignatureFD held its ANI Pharmaceuticals (ANIP) position steady in Q3 2026 at 46 shares worth $3.34K. The position accounts for ﹤0.01% of the portfolio, ranked #3054.

SignatureFD first reported a position in ANIP in Q3 2022 and has held it in 17 quarters since. The position peaked at $4.21K in Q3 2025. 291 funds tracked by Wall St. Rank hold ANIP as of Q3 2026.

  • SignatureFD held 46 shares of ANI Pharmaceuticals worth $3.34K as of Q3 2026.
  • SignatureFD left its ANI Pharmaceuticals share count unchanged in Q3 2026.
  • ANI Pharmaceuticals made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #3054 holding.
  • SignatureFD first reported a position in ANI Pharmaceuticals in Q3 2022 and has held it in 17 quarters since.
  • SignatureFD's ANI Pharmaceuticals position peaked at $4.21K in Q3 2025.
  • 291 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.